Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMEYNQA)

Drug Name
ALN-RSV01 Drug Info
Indication
Disease Entry ICD 11 Status REF
Respiratory infection CA07-CA4Z Phase 2 [1]
Respiratory syncytial virus infection 1C80 Phase 2 [2]
Cross-matching ID
TTD Drug ID
DMEYNQA

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
HRSV Nucleoprotein messenger RNA (HRSV N mRNA) TTWSF5D NCAP_HRSVA Inhibitor [3]

References

1 ClinicalTrials.gov (NCT00658086) Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV). U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT00658086) Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV). U.S. National Institutes of Health.
3 Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV). Antiviral Res. 2008 Mar;77(3):225-31.